dihexa human studies – Research Peptide dihexa human study Peptide Therapy:

A comparative study of the BPC 157 beneficial effect was done with intraperitoneal application, once daily, intraperitoneally (per kg body weight) 10 g, 10 ng, or 10 pg BPC 157, while standard agents 10 mg atropine, 50 mg ranitidine, and 50 mg omeprazole provide only a weak effect

This was a great purchase for me

A: Most clients feel energized, but very rarely, mild fatigue or dizziness may occur

On Sermorelin, Luvo Health characterizes the therapy as intended to stimulate the body's own (endogenous) growth-hormone signaling rather than replace growth hormone directly, tying it to the natural decline in growth hormone output that comes with age (sometimes called somatopause)